No headlines found.
bioAffinity Technologies Regains Compliance with Nasdaq Listing Requirements
Business Wire (Wed, 9-Sep 8:00 AM ET)
Business Wire (Thu, 3-Sep 4:30 PM ET)
bioAffinity Technologies Advances CyPath Lung for Surveillance of Lung Cancer Survivors
Business Wire (Tue, 1-Sep 8:00 AM ET)
Business Wire (Thu, 20-Aug 8:00 AM ET)
Business Wire (Tue, 18-Aug 8:00 AM ET)
PRNewswire (Fri, 14-Aug 11:45 AM ET)
Business Wire (Fri, 14-Aug 11:07 AM ET)
PRNewswire (Thu, 13-Aug 10:01 AM ET)
Business Wire (Thu, 13-Aug 9:07 AM ET)
Business Wire (Fri, 7-Aug 8:00 AM ET)
Bioaffinity Technologies - Warrant trades on the stock market under the symbol BIAFW.
As of September 11, 2026, BIAFW stock price declined to $0.24 with 6,567 million shares trading.
BIAFW has a market cap of $0.00. This is considered a Sub-Micro Cap stock.
In the last 3 years, BIAFW traded as high as $43.50 and as low as $.08.
BIAFW has underperformed the market in the last year with a return of -77.3%, while the SPY ETF gained +17.4%. In the last 3 month period, BIAFW fell short of the market, returning -90.7%, while SPY returned +3.9%. However, in the most recent 2 weeks BIAFW has outperformed the stock market by returning +217.4%, while SPY returned -0.7%.
BIAFW support price is $.31 and resistance is $.79 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BIAFW shares will trade within this expected range on the day.
